Journal articleMol Cell Proteomics2022
Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer.
- Journal
- Mol Cell Proteomics
- Published
- 7 September 2022
- Citations
- 16
- Type
- Article
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 4
- Mouse Tumor Model Shared Resource P30CA016056↗
- Pancreas cancer combination therapy based on stromal modulators and nano-carriers R21CA168454↗
- Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development R21CA234775↗
- Mechanistic Pharmacokinetics and Pharmacodynamics R35GM131800↗